Company Profiles

driven by the PitchBook Platform

Aggamin Biologics

Description

Developer of biologic drugs for diseases including preeclampsia. The company is engaged in developing and commercializing therapies for a variety of unmet diseases.

2010

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

1

Investors

Description

Developer of biologic drugs for diseases including preeclampsia. The company is engaged in developing and commercializing therapies for a variety of unmet diseases.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Pharmaceuticals

Primary Office

3960 Broadway New York, NY 10032United States +1 (212) 568-4614
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aggamin Biologics's full profile, request a free trial.

Aggamin Biologics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aggamin Biologics Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Broadview VenturesVenture CapitalMinority000 0000000 0000
Broadview Ventures Venture Capital

Aggamin Biologics Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Paul Kussie Ph.DFounder & Chief Executive Officer
Adlene Tan Ph.DSenior Scientist
Paul Kussie Ph.D Founder & Chief Executive Officer
Adlene Tan Ph.D Senior Scientist

Aggamin Biologics Board Members (1)

NameRepresentingRoleSinceContact
Info
Frederick Jones MDBroadview VenturesDirector000 0000
Frederick Jones MD Director Broadview Ventures
Request full access to PitchBook